Friedrich Graf Finckenstein - Childrens Hospital Los Angeles Research Institute Los Angeles

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 91 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Efficacy and Safety of Lifileucel Tumor-infiltrating Lymphocyte (TIL) Cell Therapy in Patients with Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study

Theresa Medina,Jason A Chesney, Harriet M Kluger,Omid Hamid,Eric D Whitman, Mike Cusnir, Sajeve S Thomas,Martin Wermke,Evidio Domingo-Musibay,Giao Q Phan,John M Kirkwood,James Larkin,Jeffrey Weber,Friedrich Graf Finckenstein,Jeffrey Chou,Brian Gastman, Xiao Wu, Rana Fiaz,Amod A Sarnaik, C-14-0 Investigators

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.101200JCO2500765-101200JCO2500765, (2025)

Cited0Views0WOSBibtex

Table S2 from Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

Adam J. Schoenfeld,Sylvia M. Lee, Bernard Doger de Spéville,Scott N. Gettinger, Simon Häfliger,Ammar Sukari,Sophie Papa, Juan F. Rodríguez-Moreno,Friedrich Graf Finckenstein,Rana Fiaz, Melissa Catlett, Guang Chen,Rongsu Qi, Emma L. Masteller,Viktoria Gontcharova, Kai He

crossref（2024）

Cited0Views0Bibtex

Figure S5 from Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

crossref（2024）

Cited0Views0Bibtex

1488 A Multicenter Phase 2 Trial of Lifileucel Plus Pembrolizumab in Patients with Checkpoint Inhibitor-Naive Metastatic NSCLC: Updated Results

Benjamin C Creelan, Kai He,Edward Garon, Jason Chesney,Sylvia Lee, Jorge Nieva,Adrian Sacher,Friedrich Graf Finckenstein,Brian Gastman,Jeffrey Chou,Rana Fiaz, Melissa Catlett, Guang Chen,Adam Schoenfeld

Late-Breaking Abstracts (2024)

Cited0Views0Bibtex

Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

Adam J. Schoenfeld,Sylvia M. Lee, Bernard Doger de Speville,Scott N. Gettinger,Simon Hafliger,Ammar Sukari,Sophie Papa,Juan F. Rodriguez-Moreno,Friedrich Graf Finckenstein,Rana Fiaz, Melissa Catlett,Guang Chen,Rongsu Qi, Emma L. Masteller,Viktoria Gontcharova,Kai He

CANCER DISCOVERYno. 8 (2024): 1389-1402

Cited8Views0WOSBibtex

Figure S1 from Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

crossref（2024）

Cited0Views0Bibtex

Table S1 from Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn